Zorrie Dimitrova, COO of GlycanAge, talks about the importance of glycans, protein biomarkers which we carry on the surfaces of every cell and which have been underexplored to date as a way of predicting health changes and disease.

The founding team behind GlycanAge are the world’s leading glycan experts and the company is pioneering a B2B2C model through a network which already includes 400 medical providers and 15,000 direct customers, more than half of which test multiple times.

They are currently raising a seed round with half of the amount committed.

Learn more about GlycanAge: [ Ссылка ]

Discover the P4SY Precision Medicine Accelerator: p4precisionmedicine.co.uk

свернуть